B-CELL MALIGNANCY

Clinical trials for B-CELL MALIGNANCY explained in plain language.

Never miss a new study

Get alerted when new B-CELL MALIGNANCY trials appear

Sign up with your email to follow new studies for B-CELL MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 6 Not yet recruiting 1 Not yet finished but already full! 1 Terminated 1

New drug HRS-1635 enters early human testing for hard-to-treat blood cancers

Disease control Not yet recruiting

This early-phase study tests the safety and tolerability of a new drug called HRS-1635 in 180 adults with B-cell blood cancers that have come back or not responded to treatment. Researchers will find the best dose and watch for side effects. The goal is to control the disease, no…

Matched conditions: B-CELL MALIGNANCY

Phase: PHASE1 • Sponsor: Chengdu Suncadia Medicine Co., Ltd. • Aim: Disease control

Last updated Jun 12, 2026 12:04 UTC

B-CELL MALIGNANCY

Get alerted when new B-CELL MALIGNANCY trials appear

New drug HRS-1635 enters early human testing for hard-to-treat blood cancers